Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

clemizole hydrochloride

The hydrochloride salt form of clemizole, an orally bioavailable histamine H1 antagonist, with potential anti-tumor and anti-allergic activities. Upon oral administration, clemizole binds to and blocks the H1 receptor, thereby preventing the interaction between histamine and the H1 receptor and inhibiting H1-mediated signaling. This may inhibit or prevent the symptoms that are caused by histamine activity and rescues or prevents allergic reactions. Although the exact mechanism of action by which clemizole appears to exert its antineoplastic effect is yet to be elucidated, clemizole inhibits the proliferation of certain tumor cell types.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allercure hydrochloride
US brand name:Reactrol
Code name:AL20
Chemical structure:1-(p-chlorobenzyl)-2-(1-pyrrolidinylmethyl)benzimidazole hydrochloride
benzimidazole, 1-(p-chlorobenzyl)-2-(1-pyrrolidinylmethyl)-, monohydrochloride
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search